Vengai Mavangira

Dr. Vengai Mavangira

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2013 in Journal of the American Veterinary Medical Association
Verified
Journal Article
Closed access
VMVengai Mavangira
Vengai Mavangira
JAJohn A. Angelos
John A. Angelos
ESEileen M. Samitz
Eileen M. Samitz
JRJoan D. Rowe
Joan D. Rowe
BBBarbara A. Byrne
Barbara A. Byrne
Case Description—6 lactating dairy goats were examined because of acute mastitis. Clinical Findings—Goats were considered to have endotoxemia on the basis of physical examination and clinicopathologic findings. The affected udder halves had gangrenous discolored distal portions with sharp demarcations from grossly normal tissue proximally. Udder secretions from the affected sides were serosanguineous in all cases. A Bacillus sp was isolated in pure cultures in all cases. In 1 case, the Bacillus sp was identified as Bacillus cereus. Treatment and Outcome—Goats were treated for mastitis and endotoxemia with polyionic IV fluid therapy, systemic and intramammary antimicrobial administration, anti-inflammatory drug administration, and other supportive treatment. All goats survived to discharge. All except 1 goat had follow-up information available. The affected udder halves sloughed in 1 to 2 months following discharge. In subsequent lactations after the mastitis episodes, milk production in 2 of 5 goats was above the mean, as determined on the basis of Dairy Herd Improvement records, and 3 of 5 goats were voluntarily withdrawn from lactation. All 5 goats had successful kiddings after the Bacillus mastitis episode. Conclusions and Clinical Relevance—Bacillus sp should be considered as a causative agent in goats with gangrenous mastitis, especially when the Bacillus sp is isolated in a pure culture. Antimicrobial sensitivity testing is recommended for selection of an appropriate antimicrobial for treatment. Prognosis for survival appears to be good, although milk production may be decreased.

1 February 2021 in Journal of Dairy Science
Verified
Journal Article
Closed access
MKM.J. Kuhn
M.J. Kuhn
VMVengai Mavangira
Vengai Mavangira
Lorraine SordilloLorraine Sordillo
Lorraine Sordillo
Dairy cattle are at the greatest risk of developing diseases around the time of calving because of compromised immune responses and the occurrence of oxidative stress. Both the development of compromised immunity and oxidative stress are influenced directly or indirectly by the metabolism of polyunsaturated fatty acids (PUFA) and fat-soluble vitamins. The cytochrome P450 (CYP450) family of enzymes is central to the metabolism of both classes of these compounds, but to date, the importance of CYP450 in the health of dairy cattle is underappreciated. As certain CYP450 isoforms metabolize both PUFA and fat-soluble vitamins, potential interactions may occur between PUFA and fat-soluble vitamins that are largely unexplored. For example, one CYP450 that generates anti-inflammatory oxylipids from arachidonic acid additionally contributes to the activation of vitamin D. Other potential substrate interactions between PUFA and vitamins A and E may exist as well. The intersection of PUFA and fat-soluble vitamin metabolism by CYP450 suggest that this enzyme system could provide an understanding of how immune function and oxidant status interconnect, resulting in increased postpartum disease occurrence. This review will detail the known contributions of bovine CYP450 to the regulation of oxylipids with a focus on enzymes that may also be involved in the metabolism of fat-soluble vitamins A, D, and E that contribute to antioxidant defenses. Although the activity of specific CYP450 is generally conserved among mammals, important differences exist in cattle, such as the isoforms primarily responsible for activation of vitamin D that makes their specific study in cattle of great importance. Additionally, a CYP450-driven inflammatory positive feedback loop is proposed, which may contribute to the dysfunctional inflammatory responses commonly found during the transition period. Establishing the individual enzyme isoform contributions to oxylipid biosynthesis and the regulation of vitamins A, D, and E may reveal how the CYP450 family of enzymes can affect inflammatory responses during times of increased susceptibility to disease. Determining the potential effect of each CYP450 on disease susceptibility or pathogenesis may allow for the targeted manipulation of the CYP450 pathways to influence specific immune responses and antioxidant defenses during times of increased risk for health disorders.

6 September 2021 in Antioxidants
Verified
Journal Article
Open access
PDF file
JSJaimie Strickland
Jaimie Strickland
LWLauren Wisnieski
Lauren Wisnieski
VMVengai Mavangira
Vengai Mavangira
Lorraine SordilloLorraine Sordillo
Lorraine Sordillo
Dairy cows experience increased oxidative stress during periods of transition such as at the cessation of lactation and around the periparturient period, thus increasing disease risk. Despite routine supplementation of transition cow diets with certain vitamins in an attempt to mitigate oxidative stress, there is no currently available data directly linking vitamin supplementation with antioxidant potential (AOP) in transition cows. The objective of this study was to determine the association between serum vitamins and biomarkers of oxidative stress in healthy cows. Blood samples were collected from 240 cows at dry off (DO), close up (CU), and 2–10 days post-calving (DIM2-10). Blood samples were analyzed for vitamins (A, D, E), β-carotene, reactive oxygen species (ROS), and AOP. Spearman correlations and mixed linear regression models were used to assess associations between vitamins and measures of oxidant status. Vitamin D concentrations were positively associated with AOP at the CU and DIM2-10. Based on the positive association with AOP, additional in-vitro studies were conducted that showed vitamin D mitigated barrier integrity loss in endothelial cells during oxidative stress. These results indicate for the first time that vitamin D may have a role in promoting antioxidant potential in transition dairy cows.

20 May 2021 in Antioxidants
Verified
Journal Article
Open access
PDF file
VMVengai Mavangira
Vengai Mavangira
MKMatthew J. Kuhn
Matthew J. Kuhn
Angel AbueloAngel Abuelo
Angel Abuelo
Christophe MorisseauChristophe Morisseau
Christophe Morisseau
BHBruce Hammock
Bruce Hammock
Lorraine SordilloLorraine Sordillo
Lorraine Sordillo
Bovine coliform mastitis presents treatment challenges because of systemic inflammation and oxidative stress. Soluble epoxide hydrolase (sEH) is a promising therapeutic target in conditions characterized by inflammation and oxidative stress but has not been evaluated in cattle. We compared sEH activity and oxidant status in healthy Holstein dairy cows to those with systemic coliform mastitis (n = 5/group) using complementary approaches. First, the activity of sEH on [3H]-trans-diphenyl-propene oxide (tDPPO) was assessed ex vivo using tissue homogenates (mammary, liver, and kidney). Second, the concentrations of sEH substrates and metabolites in plasma, milk, and urine were determined as an index of in vivo sEH activity. Oxidant status was assessed in serum and milk. Data were analyzed by non-parametric methods. Metabolism of tDPPO was greater in mammary tissues from cows with coliform mastitis compared to controls. In contrast, ratios of sEH substrates and metabolites predicted lower sEH activity in cows with coliform mastitis than controls. Milk oxidant status showed greater prooxidant levels in coliform mastitis cows. Cows with coliform mastitis exhibit increased sEH activity in mammary tissue; at the same time, milk oxidant status is increased. Future studies should characterize sEH activity and oxidant status patterns and explore therapies targeting sEH during coliform mastitis.

15 September 2008 in Journal of the American Veterinary Medical Association
Verified
Journal Article
Closed access
VMVengai Mavangira
Vengai Mavangira
TETim J. Evans
Tim J. Evans
JVJ. Armando Villamil
J. Armando Villamil
AHAllen W. Hahn
Allen W. Hahn
MCMunashe Chigerwe
Munashe Chigerwe
JTJeff W. Tyler
Jeff W. Tyler
Objective—To determine associations between age, sex, breed, and month and year of admission and the diagnosis of lead toxicosis in cattle. Design—Retrospective case-control study. Sample Population—Records of all cattle evaluated at North American veterinary teaching hospitals during the years 1963 to 2002, which were available through the Veterinary Medical Database. Procedures—Logistic regression was used to evaluate the associations between postulated risk factors and the occurrence of lead toxicosis in cattle and predict the occurrence of the diagnosis of lead toxicosis in cattle. Results—413 cases of lead intoxication and 202,363 control cattle were identified and met the inclusion criteria. Cattle < 4 years of age were at increased risk for the diagnosis of lead intoxication relative to cattle ≥ 4 years of age. Cattle ≥ 2 months and < 6 months of age had the greatest risk for lead intoxication (odds ratio, 12.3). Angus cattle were at greater risk for toxicosis (odds ratio, 1.95), compared with other breeds. The risk of lead toxicosis was greater before 1985 (odds ratio, 1.94) than the risk thereafter. The risk of lead toxicosis diagnosis was greatest in the months of May, June, July, and August. Conclusions and Clinical Relevance—Lead toxicosis in cattle was associated with age < 4 years and the Angus breed. A seasonal pattern existed with peak occurrence in the late spring and summer. The occurrence of lead toxicosis has declined over time.

1 November 2025 in Journal of Dairy Science
Verified
Journal Article
Open access
QKQuinn Kathleen Kolar
Quinn Kathleen Kolar
KKK.C. Krogstad
K.C. Krogstad
TSTurner H. Swartz
Turner H. Swartz
LML.K. Mamedova
L.K. Mamedova
VMVengai Mavangira
Vengai Mavangira
PRPamela L Ruegg
Pamela L Ruegg
Streptococcus uberis is a common mastitis pathogen that lacks an effective vaccine in the United States and often requires antibiotic therapy. Supplementation of feed with Saccharomyces cerevisiae fermentation products (SCFP) has been associated with decreased SCC in dairy cows. The objective of this randomized clinical trial was to evaluate the effect of oral supplementation with SCFP on clinical and production outcomes in lactating dairy cows in response to intramammary challenge with Streptococcus uberis. Healthy cows (n = 42; parities 1-5; >120 DIM) were enrolled if their pretrial test day SCC was <200,000 cells/mL and they had no history of clinical mastitis in the preceding 60 d. Four cohorts of cows were blocked based on bovine leukemia virus infection status, parity group, milk yield, and DIM then randomly pre-assigned to receive a challenge in one quarter before being assigned to receive a treatment or control diet during a 45-d prechallenge phase, 5- to 7-d challenge phase, and 45-d postchallenge phase. Diets of cows assigned to treatment were top-dressed with 19 g/d SCFP for 45 d, and the control cows received 19 g/d of ground corn. During the prechallenge phase, quarter milk samples were collected weekly and used to determine SCC and IMI. Cows that did not develop IMI during the prechallenge phase (n = 37) were challenged with ∼2,000 cfu of S. uberis 0140J in one rear mammary gland; quarter milk samples were collected daily until antibiotic treatment (d 5 or 7) and data collection continued for another 45 d. Statistical analyses were performed using linear mixed models. Supplementation with SCFP did not affect DMI, milk production, or milk components during the prechallenge, challenge, or postchallenge phases. During the challenge week, there was no effect of SCFP on number of colonies of S. uberis or SCC in milk. The mean time (± SE) from intramammary challenge with S. uberis until onset of clinical mastitis was 3.88 ± 0.42 d and 4.84 ± 0.44 d for cows in the control group and SCFP treated groups, respectively. The mean days to bacteriological cure were 25.9 ± 3.5 (control cows) and 22.5 ± 3.1 (SCFP treated). As compared with values in control cows, supplementation with SCFP did not affect milk yield, DMI, or SCC of cows that received an intramammary challenge with S. uberis 0140J. Interestingly in a subset of animals that were infected with bovine leukemia virus, but not lymphocytic, before challenge supplementation with SCFP increased DMI 1.3 kg ± 0.6 and increased milk production by 2.3 ± 0.9 kg/d. This study was performed using a challenge model and a single pathogen type, future studies focusing on naturally occurring mastitis may be of value.